Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB03380"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"L-Tyrosinamide"
|
| rdf:type | |
| drugbank:description |
"
4985-46-0
experimental
This compound belongs to the alpha amino acid amides. These are amide derivatives of alpha amino acids.
Alpha Amino Acid Amides
Organic Compounds
Organic Acids and Derivatives
Carboxylic Acids and Derivatives
Amino Acids, Peptides, and Analogues
Amphetamines and Derivatives
Phenylpropylamines
Phenols and Derivatives
Primary Carboxylic Acid Amides
Polyamines
Enols
Carboxylic Acids
Enolates
Monoalkylamines
amphetamine or derivative
phenylpropylamine
phenol derivative
benzene
carboxamide group
primary carboxylic acid amide
carboxylic acid
enol
polyamine
enolate
primary aliphatic amine
amine
primary amine
organonitrogen compound
L-Tyrosine amide
Tyrosinamide
logP
-0.65
ALOGPS
logS
-1.8
ALOGPS
Water Solubility
2.98e+00 g/l
ALOGPS
logP
-0.19
ChemAxon
IUPAC Name
(2S)-2-amino-3-(4-hydroxyphenyl)propanamide
ChemAxon
Traditional IUPAC Name
L-tyrosinamide
ChemAxon
Molecular Weight
180.2038
ChemAxon
Monoisotopic Weight
180.089877638
ChemAxon
SMILES
[H][C@](N)(CC1=CC=C(O)C=C1)C(N)=O
ChemAxon
Molecular Formula
C9H12N2O2
ChemAxon
InChI
InChI=1S/C9H12N2O2/c10-8(9(11)13)5-6-1-3-7(12)4-2-6/h1-4,8,12H,5,10H2,(H2,11,13)/t8-/m0/s1
ChemAxon
InChIKey
InChIKey=PQFMNVGMJJMLAE-QMMMGPOBSA-N
ChemAxon
Polar Surface Area (PSA)
89.34
ChemAxon
Refractivity
48.92
ChemAxon
Polarizability
18.56
ChemAxon
Rotatable Bond Count
3
ChemAxon
H Bond Acceptor Count
3
ChemAxon
H Bond Donor Count
3
ChemAxon
pKa (strongest acidic)
9.52
ChemAxon
pKa (strongest basic)
8.03
ChemAxon
Physiological Charge
1
ChemAxon
Number of Rings
1
ChemAxon
Bioavailability
1
ChemAxon
Rule of Five
true
ChemAxon
Ghose Filter
true
ChemAxon
PubChem Compound
151243
PubChem Substance
46507172
ChemSpider
133298
PDB
TYC
BE0003476
Pro-neuropeptide Y
Human
# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235
unknown
Pro-neuropeptide Y
NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone
NPY
Secreted
None
7.34
10852.0
Human
HUGO Gene Nomenclature Committee (HGNC)
HGNC:7955
GenAtlas
NPY
GenBank Gene Database
BC029497
UniProtKB
P01303
UniProt Accession
NPY_HUMAN
Neuropeptide Y precursor
>Neuropeptide Y
MLGNKRLGLSGLTLALSLLVCLGALAEAYPSKPDNPGEDAPAEDMARYYSALRHYINLIT
RQRYGKRSSPETLISDLLMRESTENVPRTRLEDPAMW
PF00159
Hormone_3
component
extracellular region
function
signal transducer activity
function
receptor binding
function
hormone activity
BE0004370
Valacyclovir hydrolase
Human
# Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235
unknown
Valacyclovir hydrolase
Involved in hydrolase activity
Serine hydrolase that catalyzes the hydrolytic activation of amino acid ester prodrugs of nucleoside analogs such as valacyclovir and valganciclovir. Activates valacyclovir to acyclovir. May play a role in detoxification processes
BPHL
6p25
None
9.59
32542.3
Human
HUGO Gene Nomenclature Committee (HGNC)
GNC:1094
GeneCards
BPHL
GenBank Gene Database
X81372
GenBank Protein Database
984663
UniProtKB
Q86WA6
UniProt Accession
BPHL_HUMAN
Biphenyl hydrolase-like protein
Biphenyl hydrolase-related protein
Bph-rp
Breast epithelial mucin-associated antigen
MCNAA
VACVase
>Valacyclovir hydrolase
MVAVLGGRGVLRLRLLLSALKPGIHVPRAGPAAAFGTSVTSAKVAVNGVQLHYQQTGEGD
HAVLLLPGMLGSGETDFGPQLKNLNKKLFTVVAWDPRGYGHSRPPDRDFPADFFERDAKD
AVDLMKALKFKKVSLLGWSDGGITALIAAAKYPSYIHKMVIWGANAYVTDEDSMIYEGIR
DVSKWSERTRKPLEALYGYDYFARTCEKWVDGIRQFKHLPDGNICRHLLPRVQCPALIVH
GEKDPLVPRFHADFIHKHVKGSRLHLMPEGKHNLHLRFADEFNKLAEDFLQ
>825 bp
ATGCCCAGGAATCTGCTTTATTCTCTTTTGTCCTCCCACCTGTCCCCCCATTTCAGCACC
TCGGTAACCTCTGCCAAAGTGGCTGTGAATGGCGTTCAGCTGCATTACCAGCAGACTGGA
GAGGGAGATCACGCAGTCCTGCTACTTCCTGGGATGTTAGGAAGTGGAGAGACTGATTTT
GGACCTCAGCTCAAGAACCTCAATAAGAAGCTCTTCACGGTGGTCGCCTGGGATCCTCGA
GGCTATGGACATTCCAGGCCCCCAGATCGCGATTTCCCAGCAGACTTTTTTGAAAGGGAT
GCAAAAGATGCTGTTGATTTGATGAAGGCGCTGAAGTTTAAGAAGGTTTCTCTGCTGGGG
TGGAGTGATGGGGGCATAACCGCACTCATTGCTGCTGCAAAATATCCATCTTACATCCAC
AAGATGGTGATCTGGGGCGCCAACGCCTACGTCACTGACGAAGACAGCATGATATATGAG
GGCATCCGAGATGTTTCCAAATGGAGTGAGAGAACAAGAAAGCCTCTAGAAGCCCTCTAT
GGGTATGACTACTTTGCCAGAACCTGTGAAAAGTGGGTGGATGGCATAAGACAGTTTAAA
CATCTCCCAGATGGTAACATCTGCCGGCACCTGCTGCCCCGGGTCCAGTGCCCCGCCTTG
ATTGTGCACGGTGAGAAGGATCCTCTGGTCCCACGGTTTCATGCCGACTTCATTCATAAG
CACGTGAAAGGCTCACGGCTGCATTTGATGCCAGAAGGCAAACACAACCTGCATTTGCGT
TTTGCAGATGAATTCAACAAGTTAGCAGAAGACTTCCTACAATGA
PF00561
Abhydrolase_1
function
catalytic activity
"
|
| owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt
The resource does not appear as an object